156 related articles for article (PubMed ID: 30215163)
1. The Relationship of the TLR9 and TLR2 Genetic Polymorphisms with Cervical Cancer Risk: a Meta-Analysis of Case-Control Studies.
Yang S; Liu L; Xu D; Li X
Pathol Oncol Res; 2020 Jan; 26(1):307-315. PubMed ID: 30215163
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Toll-Like Receptors 2/3/4/9 Gene Polymorphisms in Cervical Cancer Evolution.
Zidi S; Sghaier I; Gazouani E; Mezlini A; Yacoubi-Loueslati B
Pathol Oncol Res; 2016 Apr; 22(2):323-30. PubMed ID: 26548749
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Toll-like receptors in cervical cancer susceptibility among Tunisian women.
Zidi S; Verdi H; Yilmaz-Yalcin Y; Yazici AC; Gazouani E; Mezlini A; Atac FB; Yacoubi-Loueslati B
Bull Cancer; 2014 Oct; 101(10):E31-5. PubMed ID: 25373689
[TBL] [Abstract][Full Text] [Related]
4. Gene Polymorphisms of Toll-Like Receptor 9 -1486T/C and 2848G/A in Cervical Cancer Risk.
Mu X; Zhao J; Yuan X; Zhao X; Yao K; Liu Y; Zhao X
Int J Gynecol Cancer; 2015 Sep; 25(7):1173-8. PubMed ID: 26270118
[TBL] [Abstract][Full Text] [Related]
5. Association of toll-like receptor gene polymorphisms and its interaction with HPV infection in determining the susceptibility of cervical cancer in Chinese Han population.
Jin Y; Qiu S; Shao N; Zheng J
Mamm Genome; 2017 Jun; 28(5-6):213-219. PubMed ID: 28497211
[TBL] [Abstract][Full Text] [Related]
6. Association of Toll-like receptor (TLR) 2, 3 and 9 genes polymorphism with prostate cancer risk in North Indian population.
Mandal RK; George GP; Mittal RD
Mol Biol Rep; 2012 Jul; 39(7):7263-9. PubMed ID: 22311043
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Toll-like Receptor 9 polymorphism in cervical cancer development.
Roszak A; Lianeri M; Sowińska A; Jagodziński PP
Mol Biol Rep; 2012 Aug; 39(8):8425-30. PubMed ID: 22714906
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 2 gene polymorphisms and cancer susceptibility: a meta-analysis.
Wang X; Li J; Xie W; Zhang W; Chang Y
Neoplasma; 2013; 60(4):459-67. PubMed ID: 23581420
[TBL] [Abstract][Full Text] [Related]
9. TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort.
Hong J; Leung E; Fraser AG; Merriman TR; Vishnu P; Krissansen GW
J Gastroenterol Hepatol; 2007 Nov; 22(11):1760-6. PubMed ID: 17914947
[TBL] [Abstract][Full Text] [Related]
10. TLR9 gene polymorphism -1486T/C (rs187084) is associated with uterine cervical neoplasm in Mexican female population.
Martínez-Campos C; Bahena-Román M; Torres-Poveda K; Burguete-García AI; Madrid-Marina V
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2437-2445. PubMed ID: 28819773
[TBL] [Abstract][Full Text] [Related]
11. Association between genetic variants of TLR2, TLR4, TLR9 and schizophrenia.
Ayari F; Chaaben AB; Abaza H; Mihoub O; Ouni N; Boukouaci W; Kharrat M; Leboyer M; Guemira F; Tamouza R; Mankai A
Encephale; 2024 Apr; 50(2):178-184. PubMed ID: 37718198
[TBL] [Abstract][Full Text] [Related]
12. [The correlation between polymorphisms of Toll-like receptor 2 and Toll-like receptor 9 and susceptibility to gastric cancer].
Zeng HM; Pan KF; Zhang Y; Zhang L; Ma JL; Zhou T; Su HJ; Li WQ; Li JY; You WC
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jul; 45(7):588-92. PubMed ID: 22041559
[TBL] [Abstract][Full Text] [Related]
13. A Meta-Analysis for Association of XRCC3 rs861539, MTHFR rs1801133, IL-6 rs1800795, IL-12B rs3212227, TNF-α rs1800629, and TLR9 rs352140 Polymorphisms with Susceptibility to Cervical Carcinoma.
Parsaeian SF; Asadian F; Karimi-Zarchi M; Setayesh S; Javaheri A; Tabatabaie RS; Dastgheib SA; Golestanpour H; Neamatzadeh H
Asian Pac J Cancer Prev; 2021 Nov; 22(11):3419-3431. PubMed ID: 34837895
[TBL] [Abstract][Full Text] [Related]
14. Synonymous mutations in TLR2 and TLR9 genes decrease COPD susceptibility in the Chinese Han population.
Ding X; Lin Q; Zhao J; Fu Y; Zheng Y; Mo R; Zhang L; Zhang B; Chen J; Xie T; Wu H; Ding Y
Pulmonology; 2024; 30(3):230-238. PubMed ID: 37585174
[TBL] [Abstract][Full Text] [Related]
15. Absence of toll-like receptor 9 Pro99Leu polymorphism in cervical cancer.
Chauhan A; Pandey N; Raithatha N; Patel P; Desai A; Jain N
F1000Res; 2018; 7():606. PubMed ID: 30345020
[No Abstract] [Full Text] [Related]
16. Association of TLR4 and TLR9 polymorphisms and haplotypes with cervical cancer susceptibility.
Pandey NO; Chauhan AV; Raithatha NS; Patel PK; Khandelwal R; Desai AN; Choxi Y; Kapadia RS; Jain ND
Sci Rep; 2019 Jul; 9(1):9729. PubMed ID: 31278284
[TBL] [Abstract][Full Text] [Related]
17. The Associations between Toll-Like Receptor 9 Gene Polymorphisms and Cervical Cancer Susceptibility.
Tian S; Zhang L; Yang T; Wei X; Zhang L; Yu Y; Li Y; Cao D; Yang X
Mediators Inflamm; 2018; 2018():9127146. PubMed ID: 30147445
[TBL] [Abstract][Full Text] [Related]
18. TLR9 gene polymorphism (rs187084, rs352140): association with acute rejection and estimated glomerular filtration rate in renal transplant recipients.
Kim TH; Jeong KH; Kim SK; Lee SH; Ihm CG; Lee TW; Moon JY; Yoon YC; Chung JH; Park SJ; Kang SW; Kim YH
Int J Immunogenet; 2013 Dec; 40(6):502-8. PubMed ID: 23758740
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.
Li T; Huang H; Liao D; Ling H; Su B; Cai M
Mol Genet Genomics; 2015 Aug; 290(4):1235-45. PubMed ID: 25573780
[TBL] [Abstract][Full Text] [Related]
20. Genetic Polymorphisms of
Oliveira-Toré CF; Moraes AG; Martinez GF; Neves JSF; Macedo LC; Rocha-Loures MA; Quirino MG; Alves HV; Sell AM; Visentainer JEL
J Immunol Res; 2019; 2019():1492092. PubMed ID: 31781672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
